Literature DB >> 26099360

Post Splenectomy Outcome in β-Thalassemia.

Rashid H Merchant1, Ami R Shah2, Javed Ahmad2, Alka Karnik3, Nooralam Rai4.   

Abstract

OBJECTIVES: To evaluate changes in annual blood transfusion requirements and complications after splenectomy in patients with β-thalassemia.
METHODS: Forty post-splenectomy β-thalassemic patients aged 8-33 y, receiving regular blood transfusions and chelation therapy were included and non transfusion dependant patients were excluded from this retrospective cross-sectional study. Details about their surgery, transfusion requirements, and platelet levels were recorded on a standard proforma. All patients underwent a B-mode and color-coded duplex sonography of the hepatoportal system during the study period.
RESULTS: The average ferritin level in the year prior to the study was 4432 mcg/L (range 480-12,200 mcg/L). The annual blood transfusion requirement in the first year and 5 y post splenectomy [mean ± SD (138.41 ± 90.38 ml/kg/y); (116 ± 41.44 ml/kg/y)] were significantly different from requirements before splenectomy [(mean ± SD) 294.85 ± 226 ml/kg/y; p value <0.001]. There was a significant rise in platelet counts within 24 h post splenectomy with a mean rise of 4,51,000/mm(3) (p value < 0.001). During the follow up period, infections were noted in 50 % of patients, with malaria (18.75 %) being the most common. Doppler study of the portal system in one case showed portal vein thrombosis.
CONCLUSIONS: A significant sustained fall in annual blood transfusion requirement and a rise in platelet counts occurred post-splenectomy. Increase in annual blood transfusion requirement should be investigated to find the cause.

Entities:  

Keywords:  Complications; Post-splenectomy; Splenunculi; Thalassemia; Transfusion requirements

Mesh:

Year:  2015        PMID: 26099360     DOI: 10.1007/s12098-015-1792-5

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN: 0019-5456            Impact factor:   1.967


  18 in total

Review 1.  Splenic regeneration following splenectomy and impact on sepsis: a clinical review.

Authors:  Manuel Riera; Simon Buczacki; Zulfiqar A J Khan
Journal:  J R Soc Med       Date:  2009-04       Impact factor: 5.344

2.  Thromboembolic events in beta thalassemia major: an Italian multicenter study.

Authors:  C Borgna Pignatti; V Carnelli; V Caruso; F Dore; D De Mattia; A Di Palma; F Di Gregorio; M A Romeo; R Longhi; A Mangiagli; C Melevendi; G Pizzarelli; S Musumeci
Journal:  Acta Haematol       Date:  1998       Impact factor: 2.195

3.  Prospect of splenectomy in thalassemia.

Authors:  N Chaudhuri; N Samanta; S Bose; C R Maity
Journal:  Indian Pediatr       Date:  1994-08       Impact factor: 1.411

4.  A study of 42 episodes of overwhelming post-splenectomy infection: is current guidance for asplenic individuals being followed?

Authors:  D J Waghorn; R T Mayon-White
Journal:  J Infect       Date:  1997-11       Impact factor: 6.072

5.  Portal vein thrombosis after splenectomy in pediatric hematologic disease: risk factors, clinical features, and outcome.

Authors:  Tutku Soyer; Arbay O Ciftci; F Cahit Tanyel; M Emin Senocak; Nebil Büyükpamukçu
Journal:  J Pediatr Surg       Date:  2006-11       Impact factor: 2.545

6.  Prevalence of thromboembolic events among 8,860 patients with thalassaemia major and intermedia in the Mediterranean area and Iran.

Authors:  Ali Taher; Hussain Isma'eel; Ghassan Mehio; Daniela Bignamini; Antonis Kattamis; Eliezer A Rachmilewitz; Maria Domenica Cappellini
Journal:  Thromb Haemost       Date:  2006-10       Impact factor: 5.249

7.  Correlation of splenectomy with portal vein thrombosis in beta-thalassemia major.

Authors:  Mahmoodi Nesheli Hassan; Galini Moghaddam Tahereb; Tamaddoni Ahmad; Darzi Ali Asghar; Esmaeili Dooki Mohammad Reza; Bijani Ali; Mahmoodi Nesheli Mohsen
Journal:  J Pak Med Assoc       Date:  2011-08       Impact factor: 0.781

8.  Splenectomy for children with thalassemia.

Authors:  Ahmed H Al-Salem; Zaki Nasserulla
Journal:  Int Surg       Date:  2002 Oct-Dec

9.  Interaction of malaria with a common form of severe thalassemia in an Asian population.

Authors:  A O'Donnell; A Premawardhena; M Arambepola; R Samaranayake; S J Allen; T E A Peto; C A Fisher; J Cook; P H Corran; Nancy F Olivieri; D J Weatherall
Journal:  Proc Natl Acad Sci U S A       Date:  2009-10-19       Impact factor: 11.205

10.  Platelet counts in thalassemic children before and after splenectomy.

Authors:  P Hathirat; W Mahaphan; A Chuansumrit; P Pintadit; W Sasanakul; P Isarangkura
Journal:  Southeast Asian J Trop Med Public Health       Date:  1993       Impact factor: 0.267

View more
  9 in total

1.  Splenectomy for β-Thalassemia Major in Resource Challenged Settings: Often a Hobson's Choice!

Authors:  Deepak Bansal
Journal:  Indian J Pediatr       Date:  2015-08-29       Impact factor: 1.967

Review 2.  Surgical and anaesthetic outcomes of paediatric splenectomies at a tertiary care institution in South India: a retrospective cohort.

Authors:  Aureen Ruby DCunha; Ekta Rai; Tarun John K Jacob; Anup J Devasia; Grace Rebekah
Journal:  Pediatr Surg Int       Date:  2022-07-29       Impact factor: 2.003

3.  Indications and Outcomes of Splenectomy for Hematological Disorders.

Authors:  Rafiye Ciftciler; Aysel Pasayeva; Salih Aksu; Osman Ozcebe; Nilgun Sayınalp; Umit Yavuz Malkan; Yahya Buyukasık; Ibrahim C Haznedaroglu
Journal:  Open Med (Wars)       Date:  2019-06-17

4.  Impact of activated monocyte and endothelial dysfunction on coagulopathy in Egyptian adult beta thalassemic patients.

Authors:  Hanaa Abd El-Samee; Noha Bassiouny; Nermeen Nabih
Journal:  Hematol Rep       Date:  2020-11-17

Review 5.  The rare hemoglobin variant Hb Mizuho: report of a Swiss family and literature review.

Authors:  Linet Njue; Cesare Medri; Peter Keller; Miriam Diepold; Behrouz Mansouri Taleghani; Alicia Rovó
Journal:  Ann Hematol       Date:  2021-02-15       Impact factor: 3.673

6.  Achievement of Pre- and Post-Transfusion Hemoglobin Levels in Adult Transfusion-Dependent Beta Thalassemia: Associated Factors and Relationship to Reduction of Spleen Enlargement.

Authors:  Tubagus Djumhana Atmakusuma; Edison Yantje Parulian Saragih; Wulyo Rajabto
Journal:  Int J Gen Med       Date:  2021-11-01

7.  Splenectomy perspective for non-malignant hematological disorders: A cross-sectional study in the Eastern Province of KSA.

Authors:  Mortadah H Alsalman; Faisal A Al Jabr; Samma T Eraqe; Sayed I Ali; Abdallah Essa
Journal:  J Taibah Univ Med Sci       Date:  2022-03-08

8.  Using FIB-4 score as a screening tool in the assessment of significant liver fibrosis (F2) in patients with transfusion-dependent beta thalassaemia: a cross-sectional study.

Authors:  Padmapani Padeniya; Dileepa Senajith Ediriweera; Arjuna P De Silva; Madunil Anuk Niriella; Anuja Premawardhena
Journal:  BMJ Open       Date:  2022-09-26       Impact factor: 3.006

Review 9.  Bacterial Infections Following Splenectomy for Malignant and Nonmalignant Hematologic Diseases.

Authors:  Giuseppe Leone; Eligio Pizzigallo
Journal:  Mediterr J Hematol Infect Dis       Date:  2015-10-13       Impact factor: 2.576

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.